The global hyaluronidase market is expected to grow from USD 763.6 million in 2020 to USD 1,310 million by 2027, at a CAGR of 8.55% during the forecast period 2020-2027.
Hyaluronidases are a family of enzymes, which catalyze hyaluronic acid (HA) degradation. The three main groups of hyaluronidases are two forms of eukaryotic endoglycosidase hydrolases, and a glycosidase prokaryotic lyase type. They have various medical uses in cancer, skin procedures etc.
This study delivers a comprehensive analysis of product types, applications, and regions. The product type segment includes animal-derived hyaluronidase and synthetic hyaluronidase. The animal-derived hyaluronidase segment dominated the market and is expected to continue to do so over the forecast period as many commercial brands procure from animal sources. However, animal-derived hyaluronidase has its own limitations which led to the creation of synthetic hyaluronidase. On the basis of applications, the market has been divided into chemotherapy, dermatology, plastic surgery, ophthalmology, and others. The dermatology segment is expected to grow at the highest rate due to the increasing number of skin diseases. The other area that shows high growth is chemotherapy.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. With the rapid development of medical technology and improving economic conditions, the Asia-Pacific region stands as a promising market for hyaluronidase and is expected to grow at the highest CAGR during the forecast period. The APAC hyaluronidase market is poised to witness high growth in the coming years owing to the increasing number of skin disease patients, chemotherapy procedures and medical tourism. The markets in China and South Korea are proliferating, commanding significant shares in the regional market. However, the North America region is expected to hold the highest market share in terms of revenue.
Some of the notable players in the hyaluronidase market are Sun Pharmaceutical Industries, CBC Pharma, Valeant Pharmaceuticals, Amphastar Pharmaceuticals, Inc., Halozyme Therapeutics, STEMCELL Technologies, PrimaPharm Inc., Bausch & Lomb Inc, Shreya Life Sciences, and CooperSurgical Fertility among others. The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the hyaluronidase industry.
In 2019, Halozyme Therapeutics announced that its candidate for pancreatic cancer drug PEGPH20 did not achieve the key objective to boost patient lives. As such, the company set out plans to restructure, ending its oncology R&D operations in favour of increasing its portfolio of formulation product, Enhanze. The technology consists of recombinant human hyaluronidase PH20 (rHuPH20) and is used in the extracellular matrix to resolve the resistance to bulk fluid flow, allowing high amounts of large molecules to be subcutaneously supplied under the skin.
This study predicts revenue growth at global, national, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Hyaluronidase Market Analysis And Forecast, By Product Type
Global Hyaluronidase Market Analysis And Forecast, By Applications
Global Hyaluronidase Market Analysis And Forecast, By Regional Analysis
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Applications
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global Hyaluronidase Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Animal-Derived Hyaluronidase
6.3. Synthetic Hyaluronidase
7. Global Hyaluronidase Market Analysis and Forecast, By Applications
7.1. Segment Overview
7.2. Chemotherapy
7.3. Dermatology
7.4. Plastic Surgery
7.5. Ophthalmology
7.6. Others
8. Global Hyaluronidase Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Hyaluronidase Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Hyaluronidase Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Sun Pharmaceutical Industries
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. CBC Pharma
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Valeant Pharmaceuticals
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Amphastar Pharmaceuticals, Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. HalozymeTherapeutics
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. STEMCELL Technologies
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. PrimaPharm Inc.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Bausch & Lomb Inc
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
List of Table
1. Global Hyaluronidase Market, By Type , 2017–2027(USD Million)
2. Global Animal-Derived Hyaluronidase, Hyaluronidase Market, By Region, 2017–2027(USD Million)
3. Global Synthetic Hyaluronidase, Hyaluronidase Market, By Region, 2017–2027(USD Million)
4. Global Hyaluronidase Market, By Applications, 2017–2027(USD Million)
5. Global Chemotherapy Hyaluronidase Market, By Region, 2017–2027(USD Million)
6. Global Dermatology Hyaluronidase Market, By Region, 2017–2027(USD Million)
7. Global Plastic Surgery Hyaluronidase Market, By Region, 2017–2027(USD Million)
8. Global Ophthalmology Hyaluronidase Market, By Region, 2017–2027(USD Million)
9. Global Others Hyaluronidase Market, By Region, 2017–2027(USD Million)
10. Global Hyaluronidase Market, By Region, 2017–2027(USD Million)
11. Global Hyaluronidase Market, By North America, 2017–2027(USD Million)
12. North America Hyaluronidase Market, By Type , 2017–2027(USD Million)
13. North America Hyaluronidase Market, By Applications, 2017–2027(USD Million)
14. U.S. Hyaluronidase Market, By Type , 2017–2027(USD Million)
15. U.S. Hyaluronidase Market, By Applications, 2017–2027(USD Million)
16. Canada Hyaluronidase Market, By Type , 2017–2027(USD Million)
17. Canada Hyaluronidase Market, By Applications, 2017–2027(USD Million)
18. Mexico Hyaluronidase Market, By Type , 2017–2027(USD Million)
19. Mexico Hyaluronidase Market, By Applications, 2017–2027(USD Million)
20. Europe Hyaluronidase Market, By Type , 2017–2027(USD Million)
21. Europe Hyaluronidase Market, By Applications, 2017–2027(USD Million)
22. Germany Hyaluronidase Market, By Type , 2017–2027(USD Million)
23. Germany Hyaluronidase Market, By Applications, 2017–2027(USD Million)
24. France Hyaluronidase Market, By Type , 2017–2027(USD Million)
25. France Hyaluronidase Market, By Applications, 2017–2027(USD Million)
26. U.K. Hyaluronidase Market, By Type , 2017–2027(USD Million)
27. U.K. Hyaluronidase Market, By Applications, 2017–2027(USD Million)
28. Italy Hyaluronidase Market, By Type , 2017–2027(USD Million)
29. Italy Hyaluronidase Market, By Applications, 2017–2027(USD Million)
30. Spain Hyaluronidase Market, By Type , 2017–2027(USD Million)
31. Spain Hyaluronidase Market, By Applications, 2017–2027(USD Million)
32. Asia Pacific Hyaluronidase Market, By Type , 2017–2027(USD Million)
33. Asia Pacific Hyaluronidase Market, By Applications, 2017–2027(USD Million)
34. Japan Hyaluronidase Market, By Type , 2017–2027(USD Million)
35. Japan Hyaluronidase Market, By Applications, 2017–2027(USD Million)
36. China Hyaluronidase Market, By Type , 2017–2027(USD Million)
37. China Hyaluronidase Market, By Applications, 2017–2027(USD Million)
38. India Hyaluronidase Market, By Type , 2017–2027(USD Million)
39. India Hyaluronidase Market, By Applications, 2017–2027(USD Million)
40. South America Hyaluronidase Market, By Type , 2017–2027(USD Million)
41. South America Hyaluronidase Market, By Applications, 2017–2027(USD Million)
42. Brazil Hyaluronidase Market, By Type , 2017–2027(USD Million)
43. Brazil Hyaluronidase Market, By Applications, 2017–2027(USD Million)
44. Middle East and Africa Hyaluronidase Market, By Type , 2017–2027(USD Million)
45. Middle East and Africa Hyaluronidase Market, By Applications, 2017–2027(USD Million)
46. UAE Hyaluronidase Market, By Type , 2017–2027(USD Million)
47. UAE Hyaluronidase Market, By Applications, 2017–2027(USD Million)
48. South Africa Hyaluronidase Market, By Type , 2017–2027(USD Million)
49. South Africa Hyaluronidase Market, By Applications, 2017–2027(USD Million)
List of Figures
1. Global Hyaluronidase Market Segmentation
2. Hyaluronidase Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Hyaluronidase Market Attractiveness Analysis By Type
9. Global Hyaluronidase Market Attractiveness Analysis By Applications
10. Global Hyaluronidase Market Attractiveness Analysis By Region
11. Global Hyaluronidase Market: Dynamics
12. Global Hyaluronidase Market Share by Type (2019 & 2027)
13. Global Hyaluronidase Market Share By Applications (2019 & 2027)
14. Global Hyaluronidase Market Share by Regions (2019 & 2027)
15. Global Hyaluronidase Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.